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ABSTRACT  
A simple and convenient method has been developed for the synthesis of title compounds, 1-methyl-2-phenyl-1H-imidazo[4,5-f]-
quinoline and derivatives (5a-f) in reasonable yields. The commercially available 6-nitro-quinoline-5-amine (1) is used as raw 
material and it is reduced conveniently using SnCl2 to give the initial intermediate, quinoline-5,6-diamine (2) in good yield. 
Compound 2 on consecutive steps when treated on condensation followed by cyclization generated the rest of intermediates, N6-
benzylidene-quinoline-5,6-diamines (3a-f) and 2-phenyl-1H-imidazo[4,5-f]-quinolines (4a-f) respectively. The chemical structures 
of all newly prepared compounds were elucidated using infrared, 1H NMR and mass spectral studies as well as elemental analysis. 
The output of this synthetic method has been provided a series of successful biologically important structures. 
Keywords: Quinoline, imidazole, antimicrobial activity 
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INTRODUCTION 
Imidazole-based heterocyclic molecules play important 
roles in various biochemical processes
1
. Therefore, the 
imidazolyl moiety is being used as a building block in 
developing new drugs 
2, 3
. Moreover, imidazole 
derivatives have wide range applications in 
coordination chemistry
4
, organometallic catalysis
5
 and 
asymmetric catalysis
6
. Many functionalized imidazoles 
behave as antibiotics
7
, fungicides
8
, antiulceretics
9
, 
antidiabetics, antihypertensive and anti-inflammatory 
agents
10
. Consequently, it is not surprising that 
development of various strategies for their synthesis. 
Quinoline moiety is present in many classes of 
biologically active compounds
11
. The biological activity 
of these quinoline derivatives depends not only on the 
bicyclic hetero-aromatic pharmacophore but also on the 
nature of the peripheral substituent and their spatial 
relationship. They also exhibit antimalarial
12
, 
antitumor
13
, antioxidant
14
, antileishmanial
15
 and 
antiplatelet activities
16
.  
RESULTS AND DISCUSSION 
Prompted by the aforementioned findings and in the 
continuation of our ongoing research in the field of 
design, synthesis, and biological evaluation of 
heterocyclic derivatives, herein we described the 
synthesis, characterization and evaluation of a new 
series of quinoline based imidazoles as potential 
antimicrobial agents. Based on these findings, we have 
decided to explore the preparation of title compounds 
using the commercially available 6-nitro-quinoline-5-
amine (1). The synthetic route leading to the target 
compounds is outlined in Scheme 1. Thus in the initial 
step the raw material has been reduced successfully to 
generate the first intermediate, quinoline-5,6-diamine 
(2) on treatment with SnCl2 in acidic aqueous ethanol 
under reflux with constant stirring for 4 h. Afterwards, 
the formation of the next intermediate, N
6
-benzylidene-
quinoline-5,6-diamines (3a-f) was achieved when 
quinoline-5,6-diamine (2) involved in condensation 
with different aromatic aldehydes in refluxing ethanol 
with uniform stirring for 2-3 h. Subsequently, N
6
-
benzylidene-quinoline-5,6-diamines (3a-f) on 
dehydrocyclization when reacted with I2 in presence of 
DMF at reflux temperature with steady stirring for 3 h 
to turn into the final intermediate, 2-phenyl-1H-
imidazo[4,5-f]-quinolines (4a-f). Finally, the title 
compounds, 1-methyl-2-phenyl-1H-imidazo[4,5-f]-
quinolines (5a-f) have been synthesized on N-
methylation when 2-phenyl-1H-imidazo[4,5-f]-
quinolines (4a-f) reacted with dimethyl sulphate and 
NaOH in the existence of absolute ethanol on consistent 
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stirring at ambient temperature for 2 h. The chemical 
structures of all newly prepared compounds were 
elucidated using infrared, 
1
H NMR and mass spectral 
studies as well as elemental analysis. Further, the title 
compounds were found to show significant 
antimicrobial activity. 
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Scheme 1: (i) SnCl2, HCl, EtOH, Reflux, 4 h; (ii) Ph'-CHO, Ethanol, Reflux, 2-3 h; (iii) I2/DMF, reflux, 3 h; (iv) 
Me2SO4, NaOH, EtOH, 2 h.  
                   3-5 R a) = H, b) = 4-CH3, c) = 4-OCH3, d) = 4-Cl, e) = 4-Br, f) = 4-NO2 
 
Antimicrobial activity 
All the newly synthesized compounds, 1-methyl-2-
phenyl-1H-imidazo[4,5-f]-quinolines (5a-f) were used 
to screen in vitro antibacterial activity by agar diffusion 
method [17] against two gram-positive bacterial strains 
like Bacillus subtilis and Staphylococcus aureus and 
against two gram-negative bacteria such as Escherichia 
coli and Pseudomonas aeuroginosa with nutrient agar 
medium by using DMSO as solvent. The antifungal 
activity of the same compounds was also tested against 
two fungal organisms like Candida albicans and 
Aspergillus niger by agar diffusion method
17
 using 
Sabouraud dextrose agar medium by applying DMSO 
as solvent. The diameters of zone of inhibition were 
measured and compared with that of the standard drugs 
like Ciprofloxacin (50 µg/ml) for antibacterial study 
and Fuoconazole (50 µg/ml) for antifungal analysis. 
 
Table 1: Antimicrobial activity of compounds 5a-f (Zone of inhibition, mm) 
Entry                       Antibacterial activity                                            Antifungal activity 
         B.subtilis       S.aureus            E.coli             P.aeuroginosa        C.albicans           A.niger 
5a  13      08  07  09   11  10 
5b  14      11  08  14   15  13 
5c  09      09  09  08   11  08 
5d  21      22  16  24   13  18 
5e  22      23  21  16   16  17 
5f  24      22  19  14   19        20 
 
 
The consequences of the antimicrobial study are 
displayed in Table 1. As per the results, all the tested 
compounds performed varying degrees of inhibition 
against the tested microorganisms. Thus the compound 
5f with para nitro aromatic ring against B.subtilis, 
product 5e with para bromo aromatic ring moiety 
towards S.aureus and E.coli and compound 5d with 
para chloro aryl group against P.aeuroginosa disclosed 
the highest antibacterial activity. Further, the compound 
5e against B.subtilis, the compound 5d and 5f towards 
S.aureus and the compound 5f against E.coli performed 
the high antibacterial activity. Similarly, the least 
antibacterial activity has been reported by the 
compound 5c bearing para methoxy aromatic ring 
against B.subtilis and P.aeuroginosa and compound 5a 
without any substituted group on aromatic ring towards 
S.aureus and E.coli. The rest of compounds exhibited 
moderate to good antibacterial activity against the tested 
microorganisms. Finally, the highest antifungal activity 
against both fungal organisms was showed by the 
compound 5f and the least antifungal activity was 
performed by 5a and 5c towards C.albicans and the 
compound 5a towards A.niger. The remaining 
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compounds reported moderate to good antifungal 
activity against the tested microorganisms. 
Experimental section 
All reagents and solvents were used as purchased 
without further purification. Melting points were 
determined on a Fisher–Johns melting point apparatus 
and are uncorrected. Crude products were purified by 
column chromatography on silica gel of 60–120 mesh. 
IR spectra were obtained on a PerkinElmer BX series 
FT-IR 5000 spectrometer using KBr pellet. 
1
H NMR 
spectra were recorded on a Varian 300 MHz 
spectrometer. The chemical shifts were reported as ppm 
down field using TMS as an internal standard. Mass 
spectra were recorded on a VG-Micromass 7070H 
spectrometer operating at 70 eV. 
Preparation of quinoline-5,6-diamine (2) 
A solution of 6-nitro-quinoline-5-amine (1) (0.01 mol), 
SnCl2 (0.04 mol) and aqueous HCl (10 ml) in absolute 
ethanol (15 ml) was refluxed on water bath for 4 h with 
constant stirring. After consumed the whole starting 
material completely in the reaction (identified by the 
TLC), water (10 ml) was added to the reaction mixture 
and the obtained solid was filtered, collected, washed 
with cold-water and recrystallized from ethyl acetate to 
get quinoline-5,6-diamine (2) in pure form. 
Preparation of N
6
-benzylidene-quinoline-5,6-
diamines (3a-f) 
A mixture of suitable aromatic aldehyde (0.01 mol) and 
quinoline-5,6-diamine (2) (0.01 mol) in ethanol (20 ml) 
was refluxed on water bath with uniform stirring for 2-3 
h. After completion of the reaction (monitored by the 
TLC), the mixture was cooled to room temperature and 
the solvent was evaporated. The formed crude product 
was washed with cold water and it is purified by 
recrystallization from ethanol to afford the 
corresponding pure N
6
-benzylidene-quinoline-5,6-
diamines (3a-f). 
Preparation of 2-phenyl-1H-imidazo [4, 5-f]-
quinolines (4a-f) 
A solution of N
6
-benzylidene-quinoline-5, 6-diamines 
(3a-f) (0.01 ml) and iodine (0.02 mol) in dimethyl 
formamide (DMF) (10 ml) has been refluxed on water 
bath with stable stirring for 3 h. After achievement of 
the reaction (scanned by the TLC), the resulting mixture 
was poured into ice-cold water (20 ml) and the resulted 
solid was filtered, dried and recrystallized from ethyl 
acetate to obtain 2-phenyl-1H-imidazo[4,5-f]-quinolines 
(4a-f) in pure form. 
Preparation of 1-methyl-2-phenyl-1H-imidazo [4, 5-
f]-quinolines (5a-f) 
To a solution of 2-phenyl-1H-imidazo[4,5-f]-quinolines 
(4a-f) (0.01 ml) in ethanol (10 ml) was added dimethyl 
sulfate (5 ml) followed by  aqueous solution of NaOH 
(8 ml) and the reaction mixture was stirred for 2 h at 
room temperature with steady stirring. After fulfillment 
of the reaction (inspected by the TLC), the formed solid 
was collected by filtration, dried in the oven and 
recrystallized from DMF to offer pure 1-methyl-2-
phenyl-1H-imidazo[4,5-f]-quinolines (5a-f). 
Physical and spectral data 
N
6
-Benzylidene-quinoline-5,6-diamine (3a) Yellow 
solid; yield 78%; mp 142-43 °C; IR (KBr) cm
–1
: 3212 
(N-H), 3024 (C-H, Ar), 1699(C=N), 1588 (C=C, Ar); 
1
H-NMR (CDCl3) δ: 5.42 (2H, s, NH2), 7.42 (1H, d, J = 
7.4 Hz, Ar-H), 7.39-7.62 (8H, m, Ar-H), 7.54 (1H, s, 
CH=), 7.85 (1H, d, J = 7.4 Hz, Ar-H); MS m/z: 247 
(M
+
); Elemental analysis calculated for C16H13N3: C-
77.71, H-5.30, N-16.99. Found: C-76.87, H-5.28, N-
16.79. 
N
6
-(4-Methyl-benzylidene)-quinoline-5,6-diamine 
(3b) Pale yellow solid; yield 72%; mp 187-189 °C; IR 
(KBr) cm
–1
: 3318 (N-H), 3065 (C-H, Ar-H), 2984 (C-H, 
CH3), 1645 (C=N), 1548 (C=C, Ar); 
1
H-NMR (CDCl3) 
δ: 2.84 (3H, s, CH3), 5.30 (2H, s, NH2), 7.38 (2H, d, J = 
7.2 Hz, Ar-H), 7.42-7.64 (3H, m, Ar-H), 7.58 (1H, s, 
CH=), 7.67 (1H, d, J = 7.5 Hz, Ar-H), 7.70 (1H, d, J = 
7.5 Hz, Ar-H), 7.79 (2H, d, J = 7.2 Hz, Ar-H); MS m/z: 
261 (M
+
); Elemental analysis calculated for C17H15N3: 
C-78.13, H-5.79, N-16.08. Found: C-77.82, H-5.75, N-
15.89. 
N
6
-(4-Methoxy-benzylidene)-quinoline-5,6-diamine 
(3c)  
Pale yellow solid; yield 74%; mp 152-154 °C; IR (KBr) 
cm
–1
: 3236 (N-H), 3028 (C-H, Ar),  2958 (C-H, CH3), 
1648 (C=N), 1559 (C=C, Ar), 1155 (C-O); 
1
H-NMR 
(CDCl3) δ: 2.25 (3H, s, OCH3), 5.48 (2H, s, NH2), 7.35 
(2H, d, J = 7.6 Hz, Ar-H), 7.41-7.58 (3H, m, Ar-H), 
7.51 (1H, s, CH=), 7.79 (2H, d, J = 7.6 Hz, Ar-H), 7.58 
(1H, d, J = 7.1 Hz, Ar-H), 7.64 (1H, d, J = 7.1 Hz, Ar-
H); MS m/z: 277 (M
+
); Elemental analysis calculated 
for C17H15N3O: C-73.63, H-5.45, N-15.15, O-5.77. 
Found: C-72.98, H-5.44, N-15.08, O-5.75. 
N
6
-(4-Chloro-benzylidene)-quinoline-5, 6-diamine 
(3d)  
White solid; yield 72%; mp 147-149 °C; IR (KBr) cm
–1
: 
3248 (N-H), 3018 (C-H, Ar-H), 1662 (C=N), 1552 
(C=C, Ar); 
1
H-NMR (CDCl3) δ: 5.85 (2H, s, NH2), 7.37 
(2H, d, J = 7.3 Hz, Ar-H), 7.45-7.74 (3H, m, Ar-H), 
7.54 (1H, s, CH=), 7.62 (1H, d, J = 7.0 Hz, Ar-H), 7.75 
(1H, d, J = 7.0 Hz, Ar-H), 7.80 (2H, d, J = 7.3 Hz, Ar-
H); MS m/z: 281 (M
+
); Elemental analysis calculated 
for C16H12ClN3: C-68.21, H-4.29, Cl-12.58, N-14.91. 
Found: C-67.85, H-4.28, Cl-12.50, N-14.84. 
N
6
-(4-Bromo-benzylidene)-quinoline-5,6-diamine 
(3e)  
Pale yellow solid; yield 75%; mp 135-137 °C; IR (KBr) 
cm
–1
: 3245 (N-H), 3018 (C-H, Ar-H), 1638 (C=N), 
1548 (C=C, Ar); 
1
H-NMR (CDCl3) δ: 5.84 (2H, s, 
NH2), 7.32 (2H, d, J = 6.8 Hz, Ar-H), 7.41-7.74 (3H, m, 
Ar-H), 7.61 (1H, s, CH=), 7.66 (1H, d, J = 7.2 Hz, Ar-
H), 7.71 (1H, d, J = 7.2 Hz, Ar-H),7.79 (2H, d, J = 6.8 
Hz, Ar-H); MS m/z: 326 (M
+
); Elemental analysis 
calculated for C16H12BrN3: C-58.91, H-3.71, Br-24.05, 
N-12.88. Found: C-57.95, H-3.70, Br-23.87, N-12.51. 
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N
6
-(4-Nitro-benzylidene)-quinoline-5,6-diamine (3f)  
Yellow solid; yield 80%; mp 140-142 °C; IR (KBr) cm
–
1
: 3239 (N-H), 3024 (C-H, Ar-H), 1642 (C=N), 1568 
(C=C, Ar), 1550 (N-O); 
1
H-NMR (CDCl3) δ: 5.86 (2H, 
s, NH2), 7.29 (2H, d, J = 7.0 Hz, Ar-H), 7.32 (1H, d, J = 
7.2 Hz, Ar-H), 7.40 (1H, d, J = 7.2 Hz, Ar-H), 7.42-
7.81 (3H, m, Ar-H), 7.59 (1H, s, CH=), 7.85 (2H, d, J = 
7.0 Hz, Ar-H); MS m/z: 292 (M
+
); Elemental analysis 
calculated for C16H12N4O2: C-65.75, H-4.14, N-19.17, 
O-10.95. Found: C-64.98, H-4.13, N-19.01, O-10.68. 
2-Phenyl-1H-imidazo-[4,5-f]-quinoline (4a) 
Yellow solid; yield 74%; mp 126-128 °C; IR (KBr) cm
–
1
: 3240 (N-H), 3028 (C-H, Ar-H), 1654 (C=N), 1595 
(C=C, Ar); 
1
H-NMR (CDCl3) δ: 7.26 (1H, d, J = 7.4 
Hz, Ar-H), 7.38 (1H, d, J = 7.4 Hz, Ar-H), 7.46-7.76 
(8H, m, Ar-H), 10.92 (1H, s, NH); MS m/z: 245 (M
+
); 
Elemental analysis calculated for C16H11N3: C-78.35, H-
4.52, N-17.13. Found: C-77.69, H-4.50, N-17.01. 
2-p-Tolyl-1H-imidazo-[4,5-f]-quinoline (4b) 
White solid; yield 72%; mp 132-134 °C; IR (KBr) cm
–1
: 
3258 (N-H), 3032 (C-H, Ar-H), 2962 (C-H, CH3), 1664 
(C=N), 1565 (C=C, Ar); 
1
H-NMR (CDCl3) δ: 2.36 (3H, 
s, CH3), 7.16 (1H, d, J = 7.5 Hz, Ar-H), 7.26 (2H, d, J = 
7.3 Hz, Ar-H), 7.34 (2H, d, J = 7.3 Hz, Ar-H), 7.40-
7.68 (3H, m, Ar-H), 7.72 (1H, d, J = 7.5 Hz, Ar-H), 
10.86 (1H, s, NH); MS m/z: 259 (M
+
); Elemental 
analysis calculated for C17H13N3: C-78.74, H-5.05, N-
16.20. Found: C-77.45, H-5.00, N-16.02.  
2-(4-Methoxy-phenyl)-1H-imidazo-[4,5-f]-quinoline 
(4c) 
White solid; yield 79%; mp 141-143 °C; IR (KBr) cm
–1
: 
3262 (N-H), 3027 (C-H, Ar-H), 2945 (C-H, CH3), 1652 
(C=N), 1556 (C=C, Ar), 1169 (C-O); 
1
H-NMR (CDCl3) 
δ: 3.21 (3H, s, CH3), 7.26 (1H, d, J = 6.8 Hz, Ar-H), 
7.31 (2H, d, J = 7.2 Hz, Ar-H), 7.38 (2H, d, J = 7.2 Hz, 
Ar-H), 7.45-7.72 (3H, m, Ar-H), 7.78 (1H, d, J = 6.8 
Hz, Ar-H), 11.08 (1H, s, NH); MS m/z: 275 (M
+
); 
Elemental analysis calculated for C17H13N3O: C-74.17, 
H-4.76, N-15.26, O-5.81. Found: C-73.58, H-4.75, N-
15.21, O-5.79. 
2-(4-Chloro-phenyl)-1H-imidazo-[4,5-f]-quinoline 
(4d) 
White solid; yield 77%; mp 120-122 °C; IR (KBr) cm
–1
: 
3256 (N-H), 3042 (C-H, Ar-H), 1665 (C=N), 1548 
(C=C, Ar); 
1
H-NMR (CDCl3) δ: 7.22 (1H, d, J = 7.0 
Hz, Ar-H), 7.35 (2H, d, J = 7.4 Hz, Ar-H), 7.40 (2H, d, 
J = 7.4 Hz, Ar-H), 7.48-7.78 (3H, m, Ar-H), 7.84 (1H, 
d, J = 7.0 Hz, Ar-H), 11.10 (1H, s, NH); MS m/z: 279 
(M
+
); Elemental analysis calculated for C16H10ClN3: C-
68.70, H-3.60, Cl-12.67, N-15.02. Found: C-67.89, H-
3.59, Cl-12.54, N-14.92. 
2-(4-Bromo-phenyl)-1H-imidazo-[4,5-f]-quinoline 
(4e) 
Brown solid, yield: 76%, mp: 117-119 °C; IR (KBr): 
3212 (N-H), 3024 (C-H, Ar), 1645 (C=N), 1580 (C=C, 
Ar) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 7.28 (1H, 
d, J = 7.3 Hz, Ar-H), 7.38 (2H, d, J = 7.2 Hz, Ar-H), 
7.45 (2H, d, J = 7.2 Hz, Ar-H), 7.50-7.81 (3H, m, Ar-
H), 7.86 (1H, d, J = 7.3 Hz, Ar-H), 11.14 (1H, s, NH); 
MS m/z: 324 (M
+
); Elemental analysis calculated for 
C16H10BrN3: C-59.28, H-3.11, Br-24.65, N-12.96. 
Found: C-58.95, H-3.10, Br-24.54, N-12.79. 
2-(4-Nitro-phenyl)-1H-imidazo-[4,5-f]-quinoline (4f) 
Gray solid, yield: 77%, mp: 130-132 °C; IR (KBr): 
3263 (N-H), 3029 (C-H, Ar), 1581 (C=C, Ar), 1565 (N-
O) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 7.20 (1H, d, 
J = 7.5 Hz, Ar-H), 7.33 (2H, d, J = 7.4 Hz, Ar-H), 7.41 
(2H, d, J = 7.4 Hz, Ar-H), 7.46-7.74 (3H, m, Ar-H), 
7.82 (1H, d, J = 7.5 Hz, Ar-H), 11.16 (1H, s, NH); MS 
m/z: 290 (M
+
); Elemental analysis calculated for 
C16H10N4O2: C-66.20, H-3.47, N-19.30, O-11.02. 
Found: C-65.84, H-3.45, N-19.14, O-10.89. 
1-Methyl-2-phenyl-1H-imidazo-[4,5-f]-quinoline (5a) 
White solid, yield: 74%, mp: 140-142 °C; IR (KBr): 
3044 (C-H, Ar), 2984 (C-H, CH3), 1610 (C=C, Ar), 
1574 (C=N) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 
3.21(3H, s, CH3), 7.18 (1H, d, J = 7.7 Hz, Ar-H), 7.27 
(1H, d, J = 7.7 Hz, Ar-H), 7.38-7.54 (8H, m, Ar-H); MS 
m/z: 259 (M
+
); Elemental analysis calculated for 
C17H13N3: C-78.74, H-5.05, N-16.20. Found: C-77.98, 
H-5.04, N-16.02. 
1-Methyl-2-p-tolyl-1H-imidazo-[4,5-f]-quinoline (5b) 
Brown solid, yield: 75%, mp: 132-134 °C; IR (KBr): 
3039 (C-H, Ar), 2978 (C-H, CH3), 1605 (C=C, Ar), 
1568 (C=N) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 
2.31 (3H, s, CH3), 3.25 (3H, s, CH3), 7.21 (1H, d, J = 
7.3 Hz, Ar-H), 7.29 (2H, d, J = 7.6 Hz, Ar-H), 7.39 (2H, 
d, J = 7.6 Hz, Ar-H), 7.45-7.59 (3H, m, Ar-H), 7.59 
(1H, d, J = 7.3 Hz, Ar-H); MS m/z: 273 (M
+
); Elemental 
analysis calculated for C18H15N3: C-79.10, H-5.53, N-
15.37. Found: C-78.45, H-5.51, N-15.21. 
2-(4-Methoxy-phenyl)-1-methyl-1H-imidazo-[4,5-f]-
quinoline (5c) 
Orange solid, Yield: 77 %, mp: 125-127 °C. IR (KBr): 
3065 (C-H, Ar), 2968 (C-H, CH3), 1599 (C=N), 1545 
(C=C, Ar), 1110 (C-O) cm
-1
; 
1
H NMR (300 MHz, 
DMSO-d6): δ 3.18 (3H, s, CH3), 3.31 (3H, s, OCH3), 
7.28 (1H, d, J = 7.1 Hz, Ar-H), 7.34 (2H, d, J = 7.4 Hz, 
Ar-H), 7.42 (2H, d, J = 7.4 Hz, Ar-H), 7.48-7.62 (3H, 
m, Ar-H), 7.64 (1H, d, J = 7.1 Hz, Ar-H); MS m/z: 289 
(M
+
); Elemental analysis calculated for C18H15N3O: C-
74.72, H-5.23, N-14.52, O-5.53. Found: C-73.84, H-
5.21, N-14.29, O-5.50. 
2-(4-Chloro-phenyl)-1-methyl-1H-imidazo-[4,5-f]-
quinoline (5d) 
Yellow solid, Yield: 75 %, mp: 136-138 °C. IR (KBr): 
3078 (C-H, Ar), 2971 (C-H, CH3), 1584 (C=N), 1568 
(C=C, Ar) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 3.22 
(3H, s, CH3), 7.31 (1H, d, J = 7.3 Hz, Ar-H), 7.37 (2H, 
d, J = 7.5 Hz, Ar-H), 7.46 (2H, d, J = 7.5 Hz, Ar-H), 
7.45-7.59 (3H, m, Ar-H), 7.61 (1H, d, J = 7.3 Hz, Ar-
H); MS m/z: 293 (M
+
); Elemental analysis calculated 
for C17H12ClN3: C-69.51, H-4.12, Cl-12.07, N-14.30. 
Found: C-68.86, H-4.10, Cl-11.84, N-14.05. 
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2-(4-Bromo-phenyl)-1-methyl-1H-imidazo-[4,5-f]-
quinoline (5e) 
Brown solid, yield: 77%, mp: 145-147 °C; IR (KBr): 
3058 (C-H, Ar), 2970 (C-H, CH3), 1614 (C=C, Ar), 
1584 (C=N) cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ  
3.21 (3H, s, CH3), 7.24 (1H, d, J = 7.5 Hz, Ar-H), 7.35 
(2H, d, J = 7.3 Hz, Ar-H), 7.41 (2H, d, J = 7.3 Hz, Ar-
H), 7.48-7.60 (3H, m, Ar-H), 7.65 (1H, d, J = 7.5 Hz, 
Ar-H); MS m/z: 338 (M
+
); Elemental analysis 
calculated for C17H12BrN3: C-60.37, H-3.58, Br-23.63, 
N-12.42. Found: C-59.78, H-3.56, Br-23.02, N-12.01. 
2-(4-Nitro-phenyl)-1-methyl-1H-imidazo-[4,5-f]-
quinoline (5f) 
Yellow solid, Yield: 74 %, mp: 150-152 °C. IR (KBr): 
3071 (C-H, Ar), 2975 (C-H, CH3), 1584 (C=N), 1584 
(N-O), 1562 (C=C, Ar) cm
-1
; 
1
H NMR (300 MHz, 
DMSO-d6): δ 3.25 (3H, s, CH3), 7.36 (1H, d, J = 7.5 
Hz, Ar-H), 7.40 (2H, d, J = 7.7 Hz, Ar-H), 7.48 (2H, d, 
J = 7.7 Hz, Ar-H), 7.39-7.66 (3H, m, Ar-H), 7.69 (1H, 
d, J = 7.5 Hz, Ar-H); MS m/z: 304 (M
+
); Elemental 
analysis calculated for C17H12N4O2: C-67.10, H-3.97, 
N-18.41, O-10.52. Found: C-66.65, H-3.96, N-18.12, 
O-10.36. 
SUMMERY 
In conclusion, a new series of 1-methyl-2-phenyl-1H-
imidazo[4,5-f]-quinoline and derivatives (5a-f) has been 
synthesized and the antibacterial (MIC) activity of these 
compounds were also evaluated against various 
bacteria.  Many of the synthesized compounds showed 
good activity against the test bacteria and emerged as 
potential molecules for further development.  
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